300244200076

The barcode 300244200076 corresponds to Uroxatral Extended-Release Tablets, which are manufactured by Bayer Corporation/Consumer Care Div. Uroxatral (generic name: alfuzosin) is an alpha-blocker used to manage benign prostatic hyperplasia (BPH), which is a condition characterized by the enlargement of the prostate gland, leading to various urinary symptoms.

Dosage and Availability: Uroxatral is available in tablet form with recommended dosages of 10mg and 20mg. It is typically prescribed to be taken once daily, and it is important for patients to adhere strictly to the prescribed dosage. Uroxatral is a prescription medication, meaning it requires a doctor's approval to obtain.

Pricing Information: Regarding pricing, there are generally no significant variations among different retailers for Uroxatral Extended-Release Tablets. Wholesale prices for a 30-tablet supply of Uroxatral (either 10mg or 20mg) typically range from $100 to $150 USD. However, retail prices may differ based on factors such as location and the pharmacy’s pricing policies.

Health-Related Concerns: While Uroxatral is effective for managing symptoms of BPH, it is associated with certain health-related concerns, which include:

1. Postural Hypotension: Uroxatral may cause a sudden drop in blood pressure when standing up, which can lead to dizziness or even fainting.
2. Priapism: There is an increased risk of priapism (long-lasting and often painful erections), which requires immediate medical attention if it occurs.
3. Allergic Reactions: Some individuals may have allergic reactions to the medication, presenting as hives, itching, or difficulty breathing.

General Warnings: While there are no specific warnings or disclaimers related to the barcode for this product, it is advised that patients:

• Use Uroxatral as directed by their healthcare provider.
• Do not exceed the prescribed dosage.
• Contact their doctor or pharmacist if they experience any side effects.

This information is based on publicly available data, and for the most current guidelines or personal medical advice, consulting a healthcare professional is highly recommended.